PANTHERx
Founded 2011 · 731 employees on LinkedIn · 4 known investors
Find your way into PANTHERx
Sign up to see every warm intro you have to PANTHERx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PANTHERx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PANTHERx is an independent specialty pharmacy focused on rare disease care, dispensing and managing therapies for patients with rare conditions across the US. Licensed in all 50 states, it serves patients, prescribers, and manufacturers through a personalized "Rare Pharmacy" model.
Investors · 4
General Atlanticlisted by General AtlanticNew York · $10M – $1B
How we know: General Atlantic's portfolio page · funding news · Not right? Tell us
Nautic Partnerslisted by Nautic PartnersProvidence · $50M – $400M
How we know: Nautic Partners's portfolio page · funding news · Not right? Tell us
VistriareportedChicago
How we know: funding news · Not right? Tell us
Warburg PincusreportedNew York
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does PANTHERx do?
- PANTHERx is an independent specialty pharmacy focused on rare disease care, dispensing and managing therapies for patients with rare conditions across the US. Licensed in all 50 states, it serves patients, prescribers, and manufacturers through a personalized "Rare Pharmacy" model.
- Who are PANTHERx's investors?
- PANTHERx's investors include General Atlantic, Nautic Partners, Vistria, Warburg Pincus.


